Yew Bio-Pharm Group (Yew Bio-Pharm Group) Other Long Term Assets : $0.90 Mil (As of Sep. 2021)

View and export this data going back to 2013. Start your Free Trial

What is Yew Bio-Pharm Group Other Long Term Assets?

Yew Bio-Pharm Group's other long-term assets for the quarter that ended in Sep. 2021 was $0.90 Mil.

Yew Bio-Pharm Group's quarterly other long-term assets declined from Mar. 2021 ($3.92 Mil) to Jun. 2021 ($1.07 Mil) but then stayed the same from Jun. 2021 ($1.07 Mil) to Sep. 2021 ($0.90 Mil).

Yew Bio-Pharm Group's annual other long-term assets declined from Dec. 2018 ($1.82 Mil) to Dec. 2019 ($1.58 Mil) but then increased from Dec. 2019 ($1.58 Mil) to Dec. 2020 ($5.66 Mil).

Yew Bio-Pharm Group Other Long Term Assets Historical Data

The historical data trend for Yew Bio-Pharm Group's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yew Bio-Pharm Group Other Long Term Assets Chart

Yew Bio-Pharm Group Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Other Long Term Assets

Get a 7-Day Free Trial

7.15

10.55

1.82

1.58

5.66

Yew Bio-Pharm Group Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Other Long Term Assets	Get a 7-Day Free Trial															1.35	5.66	3.92	1.07	0.90

Yew Bio-Pharm Group Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Yew Bio-Pharm Group Inc (OTCPK:YEWB) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

9460 Telstar Avenue, Suite 6, El Monte, CA, USA, 91731

Website

http://www.yewbiopharm.com

Yew Bio-Pharm Group Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The company also sells raw material, including the branches and leaves of yew trees, used in the manufacturing of traditional Chinese medicines, which are used as a secondary treatment for certain cancers, meaning they must be administered in combination with other pharmaceutical drugs. The company operating business segments are China and the United States, of which the majority of its revenue comes from China.

Executives

Yongchun Shi	director	9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91302
Xiefeng Liu	director	9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Guoshuang Tian	director	9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xuehai Wu	director	9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xingming Han	director	DOOR 3, FLOOR 7, VIC NO.23 TONGZHAN ST. XIANGFANG DISTRICT HARBIN CITY F4 XXXXXXXXX
Adam C Wasserman	officer: Chief Financial Officer	1643 ROYAL GROVE WAY, WESTON FL 33327
Guifang Qi	director, officer: Treasurer	501 N. MOORE AVE. APT. A MONTEREY PARK CA 91754
Zhiguo Wang	director, officer: President and Secretary	NO. 234, GEXIN STREET NANGANG DISTRICT HARBIN CITY F4 XXXXXXXXX

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Headlines

From GuruFocus

Yew Bio-Pharm Group Announces New Cosmetic Subsidiary

By Marketwired Marketwired • 03-09-2021

Yew Bio-Pharm Group Announces New Significant Agreement

By Marketwired Marketwired • 09-12-2018

Yew Bio-Pharm Group Announces Submission of its Application to List on the Nasdaq

By Marketwired Marketwired • 09-25-2018